Combined Ketamine and Cognitive-Behavioral Therapy: Leveraging Metaplasticity to Enhance Treatment Outcomes
Focus · 2026-07 · 24 (3) · 294-306
DOI: 10.1176/appi.focus.20260001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Focus, 2026-07. Verfasst von Morgan S Hardy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, School of Medicine, Yale University, New Haven. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, School of Medicine, Yale University, New Haven.
Zitieren
APA
Hardy, M. S., Li, S. W., & Wilkinson, S. T. (2026). Combined Ketamine and Cognitive-Behavioral Therapy: Leveraging Metaplasticity to Enhance Treatment Outcomes. Focus, 24(3), 294-306. https://doi.org/10.1176/appi.focus.20260001
Vancouver
Hardy MS, Li SW, Wilkinson ST. Combined Ketamine and Cognitive-Behavioral Therapy: Leveraging Metaplasticity to Enhance Treatment Outcomes. Focus. 2026;24(3):294-306. doi:10.1176/appi.focus.20260001
BibTeX
@article{Hardy2026,
author = {Hardy, Morgan S and Li, S William and Wilkinson, Samuel T},
title = {Combined Ketamine and Cognitive-Behavioral Therapy: Leveraging Metaplasticity to Enhance Treatment Outcomes},
journal = {Focus},
year = {2026},
volume = {24},
number = {3},
pages = {294--306},
doi = {10.1176/appi.focus.20260001}
}
EUVIMED